Dry Eye Syndrome Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

In Dry Eye Syndrome Market , we mainly study the drugs and eye drops for dry eye.

Dry Eye Syndrome Market contains market size and forecasts of Dry Eye Syndrome in global, including the following market information:

Global Dry Eye Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dry Eye Syndrome Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Dry Eye Syndrome companies in 2021 (%)

The global Dry Eye Syndrome market was valued at 5540.9 million in 2021 and is projected to reach US$ 7443.2 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Artificial Tears Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dry Eye Syndrome include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM and SIMILASAN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Dry Eye Syndrome manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dry Eye Syndrome Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dry Eye Syndrome Market Segment Percentages, by Type, 2021 (%)

• Artificial Tears
• Anti-inflammatory Drugs
• Others

Global Dry Eye Syndrome Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dry Eye Syndrome Market Segment Percentages, by Distribution Channel, 2021 (%)

• Hospital
• Retail Pharmacy
• Others

Global Dry Eye Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Dry Eye Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Dry Eye Syndrome revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Dry Eye Syndrome revenues share in global market, 2021 (%)
• Key companies Dry Eye Syndrome sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Dry Eye Syndrome sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Alcon
• Novartis
• Santen Pharma
• Johnson & Johnson
• Bausch & Lomb
• Thea pharmaceuticals
• URSAPHARM
• SIMILASAN
• Akorn
• United Laboratories
• Sun Pharmaceutical
• Jianfeng Group